Quest Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Umesh Lal Shrestha, Anjan Shrestha and Ram Chandra Sanghai are competing for the second most powerful post in the private sector umbrella body.

Kathmandu, Nepal, April 10, 2014: Three candidates- Umesh Lal Shrestha, founder and managing director of Quest Pharmaceutical, Anjan Shrestha, executive director at Laxmi Group and Ram Chandra Sanghai of the Triveni Group are competing for the v

Share this article TSX Venture: QPT                                                                      EDMONTON, AB, June 1, 2021 /PRNewswire/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that clinical investigators working with OncoQuest Pharmaceuticals, Inc. ("OQP") lead clinical candidate oregovomab, will be making two presentations as part of the American Society of Clinical Oncology (ASCO) conference proceedings. OQP acquired oregovomab from OncoQuest Inc., one of the equity investee comp...

Share: TSX Venture: QPT EDMONTON, AB, Jan. 5, 2021 /CNW/ - Quest PharmaTech Inc. (TSXV:QPT) ("Quest") provides update to its June 4, 2020 news release to announce that one of its equity investee companies, OncoQuest Inc. ("OncoQuest"), completed the transfer of the immunotherapy technology assets to OncoQuest Pharmaceuticals, Inc, a KOSDAQ traded company ("OQP", 078590.KQ) on November 7, 2020. However, due to COVID-19 related Korean courts restrictions, final payment of 65,229,709 shares of OQP to OncoQuest has been delayed by one month from December 31, 2020 to January 31, 2021. In addition,...